JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klempa, B.
Right arrow Articles by Krüger, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klempa, B.
Right arrow Articles by Krüger, D. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2003, p. 4894-4897, Vol. 41, No. 10
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.10.4894-4897.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Occurrence of Renal and Pulmonary Syndrome in a Region of Northeast Germany Where Tula Hantavirus Circulates

Boris Klempa,1 Helga Meisel,1 Silvana Räth,2 Jan Bartel,3 Rainer Ulrich,1 and Detlev H. Krüger1*

Institute of Virology, Charité Medical School, Humboldt University, D-10098 Berlin,1 Department of Internal Medicine, Spreewaldklinik, D-15907 Lübben,2 Limbach Laboratory, D-69126 Heidelberg, Germany3

Received 23 December 2002/ Returned for modification 5 May 2003/ Accepted 12 July 2003


   ABSTRACT
Top
 Abstract
Case report
 References
 
Hantavirus species Tula (TULV) is carried by European common voles (Microtus spp.). Its pathogenic potential for humans is unknown. In a rural region of northeast Germany, a 43-year-old man became ill with fever, renal syndrome, and pneumonia. Typing of late acute- and convalescent-phase sera by focus reduction neutralization assay revealed the presence of neutralizing antibodies against TULV. Moreover, we detected TULV genetic material in Microtus arvalis animals that were trapped at places only a few kilometers from the home village of the patient. Phylogenetic analysis of completely sequenced genomic S segments from three virus strains grouped them within a third genetic lineage of the TULV species. This is the first case of hemorrhagic fever with renal syndrome and pulmonary involvement which can be associated with TULV infection.


   CASE REPORT
Top
 Abstract
 Case report
References
 
A 43-year-old male patient from a rural region near Cottbus (on the Northern German Plain) was admitted to the hospital. Since the previous day, he had suffered from fever (40.0°C), chills, headache, and left-thoracic, breathing-associated pain. The X-ray examination showed an infiltration within the left pulmonary midzone. The laboratory tests detected elevated levels of serum creatinine (116 µmol/liter {approx} 1.3 mg/dl), C-reactive protein (91.55 mg/liter), and a left shift in the differential blood count. Platelet count, serum bilirubin, and transaminase values were found to be normal. However, proteinuria, erythrocyturia, urobilinogenuria, and bilirubinuria were detected in urine. During the clinical course, the level of proteinuria reached a value of 4.55 g/day. No oliguria was observed, but a moderate polyuria did occur at day 7 and on the following days. With routine diagnostic methods, no evidence for acute bacterial, fungal, or viral infections (with the exception of elevated hantavirus antibody titers; see below) was found to explain the nephritis and pneumonia. A spontaneous remission of clinical symptoms and laboratory values was observed during supportive treatment of the patient. The man had not visited other countries in previous years. However, he reported that he had frequently seen and trapped rodents in a barn near his house.

At day 15, the patient was discharged from the clinic; however, at day 21 he was hospitalized again with symptoms of fever (up to 40°C), unproductive cough, and pain in the left thorax. Diagnostic radiology then demonstrated an infiltration in the basolateral segment of the lower-left lobe, whereas the primary infiltration in the left pulmonary midzone was no longer detectable. Again, elevated levels of serum creatinine and C-reactive protein were found, but this time no proteinuria occurred. Ribavirin treatment (1 g/day; Rebetol) was started and maintained over 2 weeks. Within 1 week after the second admission (day 28 after the onset of illness), the patient was free of fever and biochemical values gradually returned to normal. At day 36 after onset, the patient was finally discharged from the clinic. In the follow-up period, no clinical or laboratory deviations were observed. In particular, there was a complete remission of the pulmonary infiltration. The results of subsequent laboratory diagnostics demonstrated an acute hantavirus infection of the patient.

Hantaviruses are rodent-borne viruses which cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus pulmonary syndrome in the Americas (9, 11, 15). There is a strong association of the various hantaviruses with certain reservoir host species; for example, in Eurasia, Puumala virus (PUUV) is carried by voles, Hantaan virus (HTNV) and Dobrava virus (DOBV) are carried by Apodemus mouse species, and Seoul virus is carried by rats. Hantaviruses in the Americas are carried by New World mice, the best known examples being Sin Nombre virus and Andes virus. There is an association of renal failure with hantavirus infections in Eurasia and of lung disease with infections by American hantaviruses; however, hantavirus pulmonary syndrome cases in the Americas with renal and/or hemorrhagic involvement and HFRS cases in Europe affecting the lungs have been observed (for a short overview, see reference 9).

In the 1990s, a new PUUV-related hantavirus called Tula virus (TULV) was found in European common voles (Microtus spp.) (12, 18, 22). Since that time, TULV has been detected in voles from several European regions (1, 5, 13, 14, 19). The extent to which the virus is able to infect humans and cause disease remains unclear. A single case of (anamnestic) human infection could be found by serological evidence in a healthy blood donor, thus indicating that TULV (or a TULV-like virus) can be transmitted to humans (22). In addition, one acute case of TULV infection of a patient with fever, paronychia, and exanthema but without renal or pulmonary affection has been reported (17) and recently commented upon (2).

Here we describe the first case of HFRS associated with TULV infection. The hantavirus antibody titers against PUUV antigen as determined by immunofluorescence assay (IFA) (Progen GmbH; Heidelberg, Germany) increased from 1:128 (day 4 after onset), through 1:256 (day 15) and 1:512 (day 27), to 1:1,024 in a later serum, thereby demonstrating an acute hantavirus infection. The first serum (no. 1) available for more detailed studies was taken 27 days after the onset of symptoms. The patient gave his informed consent for participation in these investigations. Immunoglobulin G (IgG) antibodies were tested for by nucleocapsid protein-specific enzyme-linked immunosorbent assays (ELISAs) that were carried out with PUUV and HTNV antigens (Progen GmbH); results were positive. Failure of IgM-specific ELISAs to detect IgM can be explained by the disappearance of IgM within 4 weeks after onset of disease. Such disappearance of detectable IgM has also been described for other cases of hantavirus infection (3, 6). Antibody titers against PUUV (1:512)-, TULV (1:512)-, HTNV (1:32)- and DOBV (1:256)-infected cells were measured by in-house IFA. A second serum sample (no. 2) taken 7 months later confirmed these findings (Table 1). The slightly higher IFA antibody titers against the viruses of the PUUV-TULV group compared with those against the DOBV-HTNV group may indicate an infection by PUUV or a related hantavirus. However, IFA detects mainly antibodies directed against the immunodominant nucleocapsid protein and cannot be used for serotyping since anti-nucleocapsid protein antibodies exhibit cross-reactivities against the different hantavirus types (see reference 9).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Detection of hantavirus-specific antibodies in patient's serum samples

 
The focus reduction neutralization test (FRNT), which is performed under biocontainment level 3 conditions, is the only method for fine-typing sera that are positive for hantavirus antibodies. Typing of neutralizing antibodies directed against glycoproteins in the virus envelope is most representative when late acute- and convalescent-phase sera are investigated (10). Using a chemiluminescence-based FRNT (4), we have determined the neutralizing activities of serum samples 1 and 2 against PUUV, TULV, HTNV, DOBV, and Seoul virus. As shown in Table 1, an at least fourfold-higher reciprocal antibody titer was found against TULV than that found for the other viruses. This supports the assumption that TULV was the virus responsible for the infection of the patient. Nevertheless, we could not completely rule out the possibility that the infection was caused by a TULV-related, unidentified virus that was not present in the virus collection used for FRNT. To support evidence for the involvement of TULV, it was important to show that the virus is endemic to this region of Germany.

In the course of our epidemiological studies on hantavirus distribution in Germany, rodents were trapped and screened for hantavirus infections according to standard procedures (20). Infected Microtus arvalis rodents were captured in northeast Germany at two sites, both of which were a few kilometers from the home village of the patient. Hantaviral RNA was detected by reverse transcriptase PCR in tissues from 3 out of 18 animals tested. The nucleotide sequence of the complete S segment was determined by following the procedure described previously by Sibold et al. (19). In all three cases (samples D5, D17, and D63), the S segments were found to be 1,852 nucleotides in length (1,828 nucleotides if excluding the primer sequences) and were identified as belonging to the TULV species. There is no direct evidence that one of these TULV strains had caused the infection of our patient; however, these data clearly demonstrate the circulation of TULV in the area surrounding his village.

A maximum-likelihood phylogenetic tree that included the known complete S-segment sequences of other TULV strains was constructed by using the TREE-PUZZLE package (16, 21) on the basis of the Tamura-Nei evolutionary model (Fig. 1). The results show that the TULV strains can be divided into three distinct, well-supported lineages. The first lineage is represented by strains from Russia (East Europe), the second is represented by strains from the Czech Republic and West Slovakia, Croatia, and South Germany (Central and Southeast Europe), and the third is represented by strains from northeast Germany and Poland (Central Europe). Regarding the third genetic lineage, it seems reasonable to conclude that its distribution follows the Northern German Plain, which extents to Poland in the east.



View larger version (41K):
[in this window]
[in a new window]
  		FIG. 1. Maximum-likelihood phylogenetic tree of TULV strains based on complete S-segment nucleotide sequences. The TREE-PUZZLE package (16, 21) was used to reconstruct the phylogenetic tree on the basis of the Tamura-Nei evolutionary model. Missing parameters were reconstructed from the data set. The values at the tree branches represent the PUZZLE support values. TULV lineages are marked by gray background. Northeast German strains are shown in boldface type. ILVV, Isla Vista virus; PHV, Prospect Hill virus; TOPV, Topografov virus; KBRV, Khabarovsk virus; ELMCV, El Moro Canyon virus; BAYV, Bayou virus; ANDV, Andes virus; SNV, Sin Nombre virus; NYV, New York virus; SEOV, Seoul virus.

 
The clustering of TULV strains in three different genetic lineages correlates well with the geographical clustering of the locations of virus identification in three different regions of Europe. One could speculate that the host species, M. arvalis, also forms different genetic lineages. To the best of our knowledge, this has not been investigated yet on a molecular phylogenetic level; however, a study of the phylogenetic relationships within the M. arvalis species that was based on phenotypic parameters has described a postglacial remigration of three M. arvalis subspecies into Central Europe: M. arvalis arvalis from the west, M. arvalis levis from the south, and M. arvalis duplicatus from the east (8).

Our data let us conclude that TULV is circulating in northeast Germany and that the virus can be associated with both renal and pulmonary affection in humans. Clinical courses involving more patients need to be evaluated in order to define the principal signs that characterize infection by TULV. In addition to PUUV and the Apodemus agrarius-derived lineage of DOBV (references 7, 9, 20, and our unpublished data), TULV should be considered as the third Central European hantavirus with potential pathogenicity for humans.

Nucleotide sequence accession numbers. The complete S segment sequences of the TULV strains D5-98, D17-98, and D63-98 have been deposited in the GenBank sequence database under the accession numbers AF289819, AF289820 and AF289821, respectively.


   ACKNOWLEDGMENTS
 
We thank Claus Sibold, Harald Heider, and Katrin Leitmeyer for support in rodent trapping, nucleotide sequencing, and the early stages of data analysis. The excellent technical assistance by Brita Auste, Beate Ziaja, and Brigitte Pohl is gratefully acknowledged. Christian Teuscher (Lübbenau) and Gerald Mydlak (Cottbus) helped us to collect the patient's data. We thank Martin Raftery for reading the manuscript.

Our investigations were supported by Deutsche Forschungsgemeinschaft (grant no. Kr1293/2-3), the European Commission (grant no. QLK2-1999-01119), Charité Medical School, and Fonds der chemischen Industrie.

B.K. and H.M. contributed equally to this work.


   FOOTNOTES
 
* Corresponding author. Mailing address: Institute of Virology, Charité Medical School, Humboldt University, D-10098 Berlin, Germany. Phone: 49-30-450 525 092. Fax: 49-30-450 525 907. E-mail: detlev.kruger{at}charite.de. Back


   REFERENCES
Top
 Abstract
 Case report
 References
 

  1. Bowen, M. D., W. Gelbmann, T. G. Ksiazek, S. T. Nichol, and N. Nowotny. 1997. Puumala virus and two genetic variants of Tula virus are present in Austrian rodents. J. Med. Virol. 53:174-181.[CrossRef][Medline]
  2. Clement, J., J. Frans, and M. Van Ranst. 2003. Human Tula virus infection or rat-bite fever? Eur. J. Clin. Microbiol. Infect. Dis. 22:332-333.[Medline]
  3. Elgh, F., M. Linderholm, G. Wadell, A. Tärnvik, and P. Juto. 1998. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol. Med. Microbiol. 22:309-315.[CrossRef][Medline]
  4. Heider, H., B. Ziaja, C. Priemer, Å. Lundkvist, J. Neyts, D. H. Krüger, and R. Ulrich. 2001. A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies. J. Virol. Methods 96:17-23.[CrossRef][Medline]
  5. Heyman, P., J. Klingström, F. De Jaegere, G. Leclercq, F. Rozenfeld, S. Escutenaire, C. Vandenvelde, M. Zizi, A. Plyusnin, and Å. Lundkvist. 2002. Tula hantavirus in Belgium. Epidemiol. Infect. 128:251-256.[CrossRef][Medline]
  6. Kallio-Kokko, H., O. Vapalahti, Å. Lundkvist, and A. Vaheri. 1998. Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin. Diagn. Virol. 10:83-90.[CrossRef][Medline]
  7. Klempa, B., H. A. Schmidt, R. Ulrich, S. Kaluz, M. Labuda, H. Meisel, B. Hjelle, and D. H. Krüger. 2003. Genetic interaction between distinct Dobrava hantavirus subtypes of Apodemus agrarius and A. flavicollis in nature. J. Virol. 77:804-809.
  8. Kratochvil, J. 1959. Hrabos polnì. Microtus arvalis. Czechoslovak Academy of Sciences Publishers, Prague, Czech Republic.
  9. Krüger, D. H., R. Ulrich, and Å. Lundkvist. 2001. Hantavirus infections and their prevention. Microbes Infect. 3:1129-1144.[CrossRef][Medline]
  10. Lundkvist, Å., M. Hukic, J. Hörling, M. Gilljam, S. Nichol, and B. Niklasson. 1997. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J. Med. Virol. 53:51-59.[CrossRef][Medline]
  11. Mertz, G. J., B. L. Hjelle, and R. T. Bryan. 1997. Hantavirus infection. Adv. Intern. Med. 42:369-421.[Medline]
  12. Plyusnin, A., O. Vapalahti, H. Lankinen, H. Lehväslaiho, N. Apekina, Y. Myasnikov, H. Kallio-Kokko, H. Henttonen, Å. Lundkvist, M. Brummer-Korvenkontio, I. Gavrilovskaya, and A. Vaheri. 1994. Tula virus: a newly detected hantavirus carried by European common voles. J. Virol. 68:7833-7839.[Abstract/Free Full Text]
  13. Plyusnin, A., Y. Cheng, O. Vapalahti, M. Pejcoch, J. Unar, Z. Jelinkova, H. Lehvaslaiho, Å. Lundkvist, and A. Vaheri. 1995. Genetic variation in Tula hantaviruses: sequence analysis of the S and M segments of strains from Central Europe. Virus Res. 39:237-250.[CrossRef][Medline]
  14. Scharninghausen, J. J., M. Pfeffer, H. Meyer, D. S. Davis, R. L. Honeycutt, and M. Faulde. 2002. Genetic evidence for Tula virus in Microtus arvalis and Microtus agrestis in Croatia. Vector Borne Zoonotic Dis. 2:19-27.[CrossRef][Medline]
  15. Schmaljohn, C. S., and B. Hjelle. 1997. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3:95-104.[Medline]
  16. Schmidt, H. A., K. Strimmer, M. Vingron, and A. von Haeseler. 2002. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18:502-504.[Abstract/Free Full Text]
  17. Schultze, D., Å. Lundkvist, U. Blauenstein, and P. Heyman. 2002. Tula virus infection associated with fever and exanthema after a wild rodent bite. Eur. J. Clin. Microbiol. Infect. Dis. 21:304-306.[CrossRef][Medline]
  18. Sibold, C., S. Sparr, A. Schulz, M. Labuda, O. Kozuch, J. Lysy, D. H. Krüger, and H. Meisel. 1995. Genetic characterization of a new hantavirus detected in Microtus arvalis in Slovakia. Virus Genes 10:277-281.[CrossRef][Medline]
  19. Sibold, C., H. Meisel, D. H. Krüger, M. Labuda, J. Lysy, O. Kozuch, M. Pejcoch, A. Vaheri, and A. Plyusnin. 1999. Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J. Virol. 73:667-675.[Abstract/Free Full Text]
  20. Sibold, C., R. Ulrich, M. Labuda, Å. Lundkvist, H. Martens, M. Schütt, P. Gerke, K. Leitmeyer, H. Meisel, and D. H. Krüger. 2001. Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J. Med. Virol. 63:158-167.[CrossRef][Medline]
  21. Strimmer, K., and A. von Haeseler. 1997. Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment. Proc. Natl. Acad. Sci. USA 94:6815-6819.[Abstract/Free Full Text]
  22. Vapalahti, O., Å. Lundkvist, S. K. Kukkonen, Y. Cheng, M. Gilljam, M. Kanerva, T. Manni, M. Pejcoch, J. Niemimaa, A. Kaikusalo, H. Henttonen, A. Vaheri, and A. Plyusnin. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J. Gen. Virol. 77:3063-3067.[Abstract/Free Full Text]

Journal of Clinical Microbiology, October 2003, p. 4894-4897, Vol. 41, No. 10
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.10.4894-4897.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klempa, B.
Right arrow Articles by Krüger, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klempa, B.
Right arrow Articles by Krüger, D. H.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS